KR850001227B1 - Process for preparing 2-acyl-4-oxo-1,3,4,6,7,11b-hexahydro-4h-pyrazino(2,1-a)isoquinoline derivatives - Google Patents

Process for preparing 2-acyl-4-oxo-1,3,4,6,7,11b-hexahydro-4h-pyrazino(2,1-a)isoquinoline derivatives Download PDF

Info

Publication number
KR850001227B1
KR850001227B1 KR1019830002418A KR830002418A KR850001227B1 KR 850001227 B1 KR850001227 B1 KR 850001227B1 KR 1019830002418 A KR1019830002418 A KR 1019830002418A KR 830002418 A KR830002418 A KR 830002418A KR 850001227 B1 KR850001227 B1 KR 850001227B1
Authority
KR
South Korea
Prior art keywords
formula
acid
compound
pyrazino
hexahydro
Prior art date
Application number
KR1019830002418A
Other languages
Korean (ko)
Other versions
KR840009309A (en
Inventor
김충섭
이남진
Original Assignee
한국과학기술원
임관
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국과학기술원, 임관 filed Critical 한국과학기술원
Priority to KR1019830002418A priority Critical patent/KR850001227B1/en
Priority to IN823/CAL/83A priority patent/IN157936B/en
Priority to DE3324532A priority patent/DE3324532C2/en
Priority to GB08318371A priority patent/GB2126212B/en
Priority to IT67737/83A priority patent/IT1193429B/en
Priority to US06/511,999 priority patent/US4497952A/en
Publication of KR840009309A publication Critical patent/KR840009309A/en
Priority to KR1019850003493A priority patent/KR850001474B1/en
Priority to KR1019850003492A priority patent/KR850001473B1/en
Priority to IN438/CAL/85A priority patent/IN159586B/en
Application granted granted Critical
Publication of KR850001227B1 publication Critical patent/KR850001227B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Abstract

The title compounds I (R1 = H, lower alkyl, phenyl; R2=R3=H, hydroxy, C1-6 alkoxy, C1-6 aliphatic group) and their derivatives, used in the extermination of insects especially distoma, were prepared using a novel method. Thus, 1-phenyl-6-acetyl-8,8-dimethoxy3,6-diazooctane-4- on was cyclized under an acid catalyst to give 92% 1-(2-phenyl)ethyl- 4-acetyl-6-hydroxy piperazine-2-on without using a difficult process. Acids used in the reaction were selected from H2SO4, HCl, methan sulfonic acid, formic acid and p-toluene sulfonic acid, etc.

Description

2-아실-4-옥소-1,3,4,6,7,11b-헥사히드로-4H-피라지노[2,1-a]이소퀴놀린 유도체의 제조방법Method for preparing 2-acyl-4-oxo-1,3,4,6,7,11b-hexahydro-4H-pyrazino [2,1-a] isoquinoline derivative

본 발명은 다음 구조식(I)로 표시되는 2-아실-4-옥소-1,3,4,6,7,11b-헥사히드로-4H-피라지노[2,1-a]이소퀴놀린 유도체의 새롭고도 진보된 제조방법에 관한 것으로, 이들 화합물은 구충작용, 특히 디스토마 및 흡충류에 대해서 강력한 활성을 나타낸다.The present invention provides a novel novel compound of 2-acyl-4-oxo-1,3,4,6,7,11b-hexahydro-4H-pyrazino [2,1-a] isoquinoline derivative represented by the following structural formula (I): Also related to advanced methods of preparation, these compounds exhibit potent activity against antiparasitic activity, in particular against dystomosis and reptiles.

또한 이들 유도체의 일부는 중추신경계에 생물활성을 나타내며, 혈압에 영향을 주는 활성도 가지고 있다.In addition, some of these derivatives are biologically active in the central nervous system and have an effect on blood pressure.

Figure kpo00001
Figure kpo00001

구조식(I)에서, R1은 수소, 저급알킬기, 또는 페닐기이다. 저급알킬기는 탄소수가 1-6개 까지의 지방족 탄화수소이거나, 탄소수 3-7의 시클로알킬기이고, 페닐기는 벤젠고리에 탄소수 1-6의 지방족 저급알킬, 할로겐원자가 2-3개까지 치환된 페닐기이다.In formula (I), R 1 is hydrogen, lower alkyl group, or phenyl group. The lower alkyl group is an aliphatic hydrocarbon having 1 to 6 carbon atoms or a cycloalkyl group having 3 to 7 carbon atoms, and the phenyl group is an aliphatic lower alkyl having 1 to 6 carbon atoms and a phenyl group substituted with 2-3 halogen atoms in the benzene ring.

또한 R2와 R3는 수소, 히드록실기, 탄소수가 1-6개까지의 알콕시기, 또는 탄소수가 1-6개 까지의 지방족 탄화수소이다.R 2 and R 3 are hydrogen, a hydroxyl group, an alkoxy group having 1 to 6 carbon atoms, or an aliphatic hydrocarbon having 1 to 6 carbon atoms.

구조식(I)의 화합물을 제조하는 공지의 방법으로는 한국특허공보(공고번호 80-31과 80-89), 미국특허 제3,993,760(1976) 또는 Experientia 33, 1036(1977)에 여러 가지 제조 방법들이 기술되어 있다.Known methods for preparing compounds of formula (I) include various preparation methods described in Korean Patent Publications (Publication Nos. 80-31 and 80-89), US Patent Nos. 3,993,760 (1976) or Experientia 33, 1036 (1977). Described.

상기 문헌들에 기술된 방법들의 공통적인 큰 단점은 이들 제조방법들의 모두가 공업적으로 대량생산을 하기 어려운 다음 구조식(II), (III), (IV)의 중가체 화합물을 제조하는 공정을 거쳐야 한다는 점이다.A common major disadvantage of the methods described in the above documents is that all of these preparation methods have to go through the process of preparing the heavy-weight compounds of the following structural formulas (II), (III) and (IV) which are difficult to industrially mass-produce. Is that.

Figure kpo00002
Figure kpo00002

즉, 구조식(II)의 화합물은 이소퀴놀린을 아실클로라이드와 알칼리금속시안화물과 반응시켜 얻은 라이서트 화합물(Reissert's compound)을 촉매존재하에 고온(100℃)과 고압(100기압)의 반응으로 공지의 특허(미국특허 3,993,760호)에서 수소환원에 의해서 제조할 수 있으므로 고온, 고압에 의한 장치와 수소환원에 의한 안전도가 문제가 된다. 구조식(III)의 화합물도 공지의 특허(한국특허공보 공고번호 80-30호)에서 기술한 것처럼 페닐글리옥살에서 출발하여 여러 단계(6-8개)의 반응을 거쳐야 함은 물론, 각 단계마다 수율이 좋지 못하기 때문에 공업적인 제법은 되지 못한다.That is, the compound of formula (II) is known as a reaction of Resert's compound obtained by reacting isoquinoline with acyl chloride and alkali metal cyanide at high temperature (100 ° C.) and high pressure (100 atmospheres) in the presence of a catalyst. In the patent (US Pat. No. 3,993,760), it can be produced by hydrogen reduction, so the safety due to the high temperature, high pressure and hydrogen reduction is a problem. Compounds of formula (III) also have to start with phenylglyoxal and undergo several stages of reaction (6-8) as described in known patents (Korean Patent Publication No. 80-30). Yields are not good, it is not an industrial recipe.

끝으로 Experientia 33, 1036(1977)에서는 구조식(IV)의 화합물에서 출발하여 구조식(I)의 화합물을 제조할 수 있다고 기술하고 있으나, 구조식(IV)의 합성방법이나 이 공정에 의한 각 반응 중간체의 구조 확인에 관한 자료가 기술되어 있지 않았기 때문에 실용적인 합성공정이 되지 못한다.Finally, Experientia 33, 1036 (1977) states that compounds of formula (I) can be prepared starting from compounds of formula (IV), but the synthesis method of formula (IV) or the reaction intermediate of each reaction intermediate Since no data on structural identification have been described, it is not a practical synthesis process.

본 발명은 앞에서 기술한 공지의 방법과는 전혀 다르며, 어려운 반응공정이 필요치 않은 경제적이고도 진보성이 있는 새로운 방법으로서, 본 발명의 출발물질인 구조식(V)나 (VI)의 화합물을 간단한 합성방법에 의해서 높은 수율로 제조하고 이들을 산 촉매 존재하에 고리화 반응에 의해서 구조식(I)의 화합물을 제조하는 방법이다. 본 발명은 또한 구조식(I)나 (VI)의 출발물질로부터 반응 조건에 따라서는 직접구조식(I)의 화합물이 제조될 수 있고, 고리화 반응의 중간체인(VII)나 (VIII)의 화합물을 분리하여 구조식(I)의 화합물이 제조할 수도 있다.The present invention is an economical and advanced new method that is completely different from the known methods described above, and does not require a difficult reaction process. The compounds of the structural formulas (V) and (VI), which are the starting materials of the present invention, are used in a simple synthesis method. It is a method for preparing a compound of formula (I) by the cyclization reaction in the presence of an acid catalyst prepared in high yield. The present invention also provides compounds of formula (I) which can be prepared directly from the starting materials of formula (I) or (VI), depending on the reaction conditions, and which are intermediates of the cyclization reaction (VII) or (VIII). The compounds of formula (I) may also be prepared separately.

Figure kpo00003
Figure kpo00003

구조식(V)나 (VI)의 화합물에서 R4는 메틸, 에틸 또는 2개의 R4기가 메틸렌기로서 고리를 형성하고 있는 아세틸을 나타낸다.R 4 in the compounds of formula (V) or (VI) represents methyl, ethyl or acetyl in which two R 4 groups form a ring as methylene group.

구조식(V)나 (VI)의 화합물에서 구조식(I), (VII), (VIII)의 화합물을 제조할 때 사용되는 산촉매로는 황산, 염산, 인산, 폴리인산, 포름산, 아세트산, 메탄설폰산, 트리플루오로아세트산, 트리클로로아세트산, 보론트리플루오로에테르 부가물, p-톨루엔 설폰산을 반응 용매겸 촉매로 사용하거나, 또는 C1-C2의 염화탄화수소(메틸렌디클로라이드, 디클로로에탄, 클로로포름, 사염화탄소), 니트릴(아세토니트릴), 에테르(디에틸에테르, 테트라히드로푸탄, 디옥산 등)과 같은 용매와 같이 이들 산을 촉매로 사용할 수 있다.Acid catalysts used in the preparation of compounds of formulas (I), (VII) and (VIII) from compounds of formula (V) or (VI) include sulfuric acid, hydrochloric acid, phosphoric acid, polyphosphoric acid, formic acid, acetic acid, methanesulfonic acid , Trifluoroacetic acid, trichloroacetic acid, borontrifluoroether adduct, p-toluene sulfonic acid are used as a reaction solvent and catalyst, or C 1 -C 2 hydrocarbon chlorides (methylenedichloride, dichloroethane, chloroform These acids can be used as catalysts, such as solvents such as carbon tetrachloride, nitrile (acetonitrile) and ethers (diethyl ether, tetrahydrobutane, dioxane, etc.).

구조식(V)나 (VI)의 화합물에서 직접 구조식(I)의 화합물을 제조하는 가장 적합한 반응조건은 황산이나 메탄설폰산을 용매로 사용하여 상온에서 3-5시간 반응시키는 것이다. 중간체(VII)의 화합물은 상기 조건에서 구조식(V)화합물로부터 짧은 시간(1시간 이내) 반응시킨 반응물을 알칼리성 수용액에 가하여 얻는다. 구조식(VIII)의 중간체는 구조식(V)나 (VI)의 화합물을 앞에서 열거한 산을 촉매로 하여 용매존재하에서 반응시켜 얻는다.The most suitable reaction condition for preparing the compound of formula (I) directly from the compound of formula (V) or (VI) is 3-5 hours at room temperature using sulfuric acid or methanesulfonic acid as a solvent. The compound of intermediate (VII) is obtained by adding a reactant reacted for a short time (within 1 hour) from the compound of formula V under the above conditions to an aqueous alkaline solution. The intermediate of formula (VIII) is obtained by reacting a compound of formula (V) or (VI) in the presence of a solvent with the acid listed above as a catalyst.

가장 바람직한 조건은 20% 염산에서 반응시키거나 또는 앞에서 열거한 산을 10%몰비로 가하고 용매중에서 환류반응시키는 것이다.Most preferred conditions are to react in 20% hydrochloric acid or to add the above-mentioned acids in a 10% molar ratio and reflux in a solvent.

구조식(V)나 (VI)의 화합물에서 구조식(VII)이나 (VIII)의 화합물이 얻어질 수 있고, 또한 이들 중간체로부터 구조식(I)이 제조될 수 있다는 이론적인 근거는 문헌[Tet. Letters, No.44, 44493(1972)와 ibid, No. 11, 935(1977)]에 기술된 반응에서 설명될 수 있다. 그러나 본 발명에서 이용되는 반응은 구조식(I)화합물의 피라지노 고리와 이소퀴놀린고리를 동시에 형성시키는 자금까지는 공지되어 있지 않은 새로운 반응이며, 이소퀴놀린의 붙은 고리계 화합물의 합성에 응용될 수 있는 아주 진보적인 방법이다.The rationale that compounds of formula (VII) or (VIII) can be obtained from compounds of formula (V) or (VI) and that formula (I) can be prepared from these intermediates are also described in Tet. Letters, No. 44, 44493 (1972) and ibid, No. 11, 935 (1977). However, the reaction used in the present invention is a new reaction that is not known until the fund for simultaneously forming the pyrazino ring and the isoquinoline ring of the compound of formula (I), and can be applied to the synthesis of the attached ring-based compound of isoquinoline. It's a progressive way.

구조식(V)나 (VI)의 화합물은 질소원자를 중심으로 하여 4가지 출발물질로 부터 합성할 수 있다. 즉, 구조식(V) 화합물의 경우 펜에틸아민 유도체와 모노클로로아세틸클로라이드를 공지[JACS, 55, 2555(1983)]의 방법으로 반응시켜 구조식(IX)의 중간체를 합성하고 이 화합물을 아미노아세트알데히드알킬아세틸과 반응시켜 구조식(X)의 화합물을 얻은 다음, 상응하는 카르복실산클로라이드와 반응시켜 구조식(V)의 화합물을 얻을 수 있다.Compounds of formula (V) or (VI) can be synthesized from four starting materials centered on nitrogen atoms. That is, in the case of the compound of formula (V), the phenethylamine derivative and the monochloroacetyl chloride are reacted by the method of the known method [JACS, 55, 2555 (1983)] to synthesize an intermediate of the formula (IX), and the compound is aminoacetaldehyde. The compound of formula (V) can be obtained by reaction with alkylacetyl to give a compound of formula (X) and then the corresponding carboxylic acid chloride.

또한, 글리신과 브로모아세트알데히드디알킬아세탈과 반응시켜 얻은 구조식(XI)의 화합물을 상응하는 카르복실산클로라이드와 반응시켜 구조식(XII)의 화합물을 얻은 다음 펜에틸아민 유도체와 반응시켜 구조식(V)의 화합물을 얻을 수도 있다.In addition, a compound of formula (XI) obtained by reacting glycine with bromoacetaldehyde dialkyl acetal is reacted with a corresponding carboxylic acid chloride to obtain a compound of formula (XII), and then reacted with a phenethylamine derivative to give a formula (V ) Compound can also be obtained.

Figure kpo00004
Figure kpo00004

또한 구조식(V)의 화합물은 염기(알칼리금속알콕시드) 존재하에 N-(2,3-디알콕시) 에틸아실아미드(XIII)와 구조식(IX)의 화합물을 반응시켜서 얻을 수 있다.The compound of formula (V) can also be obtained by reacting N- (2,3-dialkoxy) ethylacylamide (XIII) with a compound of formula (IX) in the presence of a base (alkali metal alkoxide).

Figure kpo00005
Figure kpo00005

구조식(VI)의 화합물은 N-(2,2-디알콕시)에틸 펜에틸아민 유도체(XIV : 펜에틸아민 유도체와 할로아세트알데히드알킬 아세탈과의 반응에 의하여 용이하게 얻음)을 N-아실글리신과 반응시켜 제조한다.The compound of formula (VI) is obtained by the reaction of N- (2,2-dialkoxy) ethyl phenethylamine derivative (XIV: easily obtained by reaction of phenethylamine derivative with haloacetaldehydealkyl acetal) with N-acylglycine. It is made by reaction.

Figure kpo00006
Figure kpo00006

또한 구조식(VI)의 화합물은 구조식(XIV)의 화합물에 모노 클로로아세틸클로라이드를 반응시켜 얻은 구조식(XV)의 화합물에 카르복실산아미드를 반응시켜 얻을 수 있다.In addition, the compound of formula (VI) can be obtained by reacting carboxylic acid amide with the compound of formula (XV) obtained by reacting mono chloroacetyl chloride with the compound of formula (XIV).

Figure kpo00007
Figure kpo00007

이와 같이 본 발명의 출발물질인 구조식(V)나 (VI)의 화합물은 여러 가지 출발물질을 사용하여 위에서 기술한 방법에 의해 합성될 수 있기 때문에 에떤 특정한 출발물질을 사용하여야 하는 방법과 비교할 때 본 발명의 장점이 있다.As such, the compounds of formula (V) or (VI), which are the starting materials of the present invention, can be synthesized by the methods described above using various starting materials. There is an advantage of the invention.

다음의 실시예들은 본 발명의 기술적인 문제를 자세히 설명하여 줄 것이나, 본 발명이 반드시 이 범위에 국한되는 것은 아니다.The following examples will illustrate the technical problem of the present invention in detail, but the present invention is not necessarily limited to this range.

[실시예 1]Example 1

1-(2-페닐)에틸-4-아세틸-6-히드록시피페라진-2-온1- (2-phenyl) ethyl-4-acetyl-6-hydroxypiperazin-2-one

(VII : R1=메틸, R2=R3=수소)(VII: R 1 = methyl, R 2 = R 3 = hydrogen)

1-페닐-6-아세틸-8,8-디메톡시-3,6-디아조옥탄-4-온 3.08g(0.01몰)을 진한황산 5㎖에가하고, 상온에서 30분간 교반후 10% 가성소다 수용액에 냉각하면서 서서히 가한다.3.08 g (0.01 mol) of 1-phenyl-6-acetyl-8,8-dimethoxy-3,6-diazooctan-4-one was added to 5 ml of concentrated sulfuric acid, stirred at room temperature for 30 minutes, and then 10% caustic. It is slowly added to the aqueous solution of soda while cooling.

중화액을 디클로로메탄으로 추출하고 건조 후 용매를 제거한 후 잔사를 에틸아세레이트-헥산으로 재결정하면 백색고체 2.4g(92%)을 얻는다.The neutralized solution was extracted with dichloromethane, dried, the solvent was removed, and the residue was recrystallized with ethyl acetate-hexane to obtain 2.4 g (92%) of a white solid.

m.p. : 128-129℃, nmr(CDCl3)δ : 2.05(S,3, COCH3), 2.65-4.80(m,10,CH2,CH), 7.20(S,5, 벤젠환수소), IR(KBr)cm-1: 3350(S, OH), 2930(m, CH), 1650(S, CO), 1420-1480(S), 1170(S)mp: 128-129 ° C., nmr (CDCl 3 ) δ: 2.05 (S, 3, COCH 3 ), 2.65-4.80 (m, 10, CH 2 , CH), 7.20 (S, 5, benzene cyclic hydrogen), IR (KBr) cm -1 : 3350 (S, OH), 2930 (m, CH), 1650 (S, CO), 1420-1480 (S), 1170 (S)

[실시예 2]Example 2

1-(2-페닐)에틸-4-시클로헥산카르보닐-1,2,3,4-테트라히드로피라진-2-온1- (2-phenyl) ethyl-4-cyclohexanecarbonyl-1,2,3,4-tetrahydropyrazin-2-one

(VIII : R1=시클로헥실, R2=R3=수소)(VIII: R 1 = cyclohexyl, R 2 = R 3 = hydrogen)

1-페닐-3-(2,2-디엑톡시)에틸-7-시클로헥실-3,6-디아자헵탄-4,7-디온4.0g(0.01몰)을 디클로로메탄 10㎖에 용해시키고 메탄1㎖를 가한 후 상온에서 3시간 교반한다. 반응액을 알칼리 수용액으로 세척한 후 유기층을 건조하고 용매를 제거한 후 잔사를 에탈아세테이트-헥산으로 재결정하면 백색고체 2.8g(90%)을 얻는다.4.0 g (0.01 mol) of 1-phenyl-3- (2,2-diethoxy) ethyl-7-cyclohexyl-3,6-diazaheptan-4,7-dione was dissolved in 10 ml of dichloromethane and After adding ㎖ and stirred at room temperature for 3 hours. After the reaction solution was washed with an aqueous alkali solution, the organic layer was dried, the solvent was removed, and the residue was recrystallized with etaacetate-hexane to obtain 2.8 g (90%) of a white solid.

m.p. : 128-130℃, nmr(CDCl3)δ : 0.85-2.0(m,10, 시클로헥산환수소), 2.90(t,2,CH2), 3.70(t,2,CH2), 4.20(S,2,CH2) 5.30(d,1, 비닐수소), 6.00(d,1, 비닐수소), 7.10(s,t, 벤젠환수소), IR(KBr)cm-1: 2930(m,CH), 1660(S, CO), 1450, 1400(m), 1300(m), 1000(m), 700(w)mp: 128-130 ° C., nmr (CDCl 3 ) δ: 0.85-2.0 (m, 10, cyclohexanecyclohydrogen), 2.90 (t, 2, CH 2 ), 3.70 (t, 2, CH 2 ), 4.20 ( S, 2, CH 2 ) 5.30 (d, 1, vinyl hydrogen), 6.00 (d, 1, vinyl hydrogen), 7.10 (s, t, benzenebenzenehydrogen), IR (KBr) cm -1 : 2930 (m, CH), 1660 (S, CO), 1450, 1400 (m), 1300 (m), 1000 (m), 700 (w)

[실시예 3]Example 3

2-시클로헥산카르보닐-4-옥소-1,2,3,6,7,11b-헥사히드로-4H-피라지노[2, 1-a]이소퀴놀린(I : R1-시클로헥산카르보닐, R2=R3=수소)2-cyclohexanecarbonyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino [2, 1-a] isoquinoline (I: R 1 -cyclohexanecarbonyl, R 2 = R 3 = hydrogen)

1-(2-페닐)에틸-4-시클로헥산카르보닐-6-히드록시피페라진-2-은(실시예 1과 같은 방법에 의해서 제조) 3.3g(0.01몰)을 진한황산 5㎖에 가하고 3시간 상온에서 교반한다. 반응액을 얼음물에 가하고 알칼리로 중화한 후 디클로로메탄으로 추출한다.3.3 g (0.01 mol) of 1- (2-phenyl) ethyl-4-cyclohexanecarbonyl-6-hydroxypiperazine-2-silver (produced by the same method as in Example 1) was added to 5 ml of concentrated sulfuric acid. Stir at room temperature for 3 hours. The reaction solution is added to ice water, neutralized with alkali and extracted with dichloromethane.

추출액을 건조하고 용매를 제거한 후 잔사를 에틸아세테이트로 재결정하면 백색고체 3.0(95%)을 얻는다. m.p. : 132-134℃The extract was dried, the solvent was removed and the residue was recrystallized from ethyl acetate to give a white solid 3.0 (95%). m.p. : 132-134 ℃

[실시예 4]Example 4

2-아세틸-4-옥소-1,2,3,6,7,11b-헥사히드로-4H-피라지노[2, 1-a] 이소퀴놀린(I : R1-메틸 R2=R3=수소)2-acetyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino [2, 1-a] isoquinoline (I: R 1 -methyl R 2 = R 3 = hydrogen )

1-(2-페닐)에틸-4-아세틸-1,2,3,4-테트라히드로피라진-2-온(실시예 2과 같은 방법에 의해서 제조) 2.4g(0.01몰)을 디클로에탄 10㎖에 용해시키고 메탄설폴산 3㎖를 가한후 3시간 환류 반응시킨다. 반응액을 알칼리로 세척하고 유기층을 건조후 용매를 제거하면 조제품 2.1g(86%)을 얻는다. 에틸아세테이트로 재결정하면 녹는점이 144-145℃인 순수한 제품을 얻는다.2.4 g (0.01 mol) of 1- (2-phenyl) ethyl-4-acetyl-1,2,3,4-tetrahydropyrazin-2-one (prepared by the same method as Example 2) was added to dichloroethane 10 The solution was dissolved in ㎖, and 3 ml of methanesulfonic acid was added, followed by refluxing for 3 hours. The reaction solution was washed with alkali, the organic layer was dried and the solvent was removed to obtain 2.1 g (86%) of the crude product. Recrystallization with ethyl acetate gives a pure product with a melting point of 144-145 ° C.

nmr(CDCl3)δ : 2.20(S,3,COCH3), 2.50-5.30(m,9,CH2,CH), 7.10(S,4, 벤젠환수소)nmr (CDCl 3 ) δ: 2.20 (S, 3, COCH 3 ), 2.50-5.30 (m, 9, CH 2 , CH), 7.10 (S, 4, benzenebenzene)

[실시예 5]Example 5

1-(2-페닐)에틸-4-시클로헥산카르보닐-1,2,3,4-테트라히드로파라진-2-온,1- (2-phenyl) ethyl-4-cyclohexanecarbonyl-1,2,3,4-tetrahydroparazin-2-one,

(VIII : R1=시클로헥실, R2=R3=수소)(VIII: R 1 = cyclohexyl, R 2 = R 3 = hydrogen)

1-페닐-6-시클롤헥산카르보닐-8,8-디메톡시-3,6-디아자옥탄-4-온 3.8g(0.01몰)을 20% 염산 5㎖에 가하고 상온에서 3시간 교반 반응시킨다.3.8 g (0.01 mol) of 1-phenyl-6-cyclohexanecarbonyl-8,8-dimethoxy-3,6-diazaoctan-4-one was added to 5 ml of 20% hydrochloric acid and stirred at room temperature for 3 hours. Let

생성된 고체를 여과하고 물로 수회 세척 후 건조하면 백색고체 2.9g(93%)을 얻는다.The resulting solid was filtered, washed several times with water and dried to yield 2.9 g (93%) of a white solid.

m.p : 129-131℃m.p: 129-131 ℃

[실시예 6]Example 6

2-d-클로로벤조일-4-옥소-9,10-디메톡시-1,2,3,6,7,11b-헥사히드로-4H-피라지노[2,1-a] 이소퀴놀린(I : R1=p-클로로벤조일, R2=R3=메톡시)2-d-chlorobenzoyl-4-oxo-9,10-dimethoxy-1,2,3,6,7,11b-hexahydro-4H-pyrazino [2,1-a] isoquinoline (I: R 1 = p-chlorobenzoyl, R 2 = R 3 = methoxy)

1-(3,4-디메톡시)페닐-3-(2,2-디에톡시)에틸-7-(4-클로로)페닐-3,6-디아자헵탄-4,7-디온 4.9g(0.01몰)을 클로로포름 10㎖에 용해시키고 보론트리플루오로에테르 부가물 1㎖를 가한 후 3시간 환류반응시킨다.4.9 g (0.01) of 1- (3,4-dimethoxy) phenyl-3- (2,2-diethoxy) ethyl-7- (4-chloro) phenyl-3,6-diazaheptan-4,7-dione Mole) is dissolved in 10 ml of chloroform, 1 ml of boron trifluoroether adduct is added, and the mixture is refluxed for 3 hours.

반응액을 물로 세척하고 유기층을 건조한 후 용매 제거후 잔사를 에틸아세테이트-에테르로 재결정하면 백색고체 3.3g(82%)을 얻는다.The reaction solution was washed with water, the organic layer was dried, the solvent was removed, and the residue was recrystallized with ethyl acetate-ether to obtain 3.3 g (82%) of a white solid.

m.p. : 138-140℃, IR(KBr)cm-1: 2920,2850(m,CH), 1640,1660(S,C=O), 1510, 1420, 1230, 1170(S), 840, 750(m)mp: 138-140 ° C, IR (KBr) cm -1 : 2920,2850 (m, CH), 1640,1660 (S, C = O), 1510, 1420, 1230, 1170 (S), 840, 750 ( m)

[실시예 7]Example 7

2-아세틸-4-옥소-1,2,3,6,7,11b-헥사히드로-4H-피라지노[2, 1-a] 이소퀴놀린(I : R1-메틸, R2=R3=수소)2-acetyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino [2, 1-a] isoquinoline (I: R 1 -methyl, R 2 = R 3 = Hydrogen)

1-페닐-6-아세틸-8,8-디메톡시-3,6-디아자옥탄-4-온 3.1g(0.01몰)을 폴리인산 10㎖에 가하고 상온에서 3시간 교반 후 얼음물에 희석시킨다. 희석액에 포화탄산나트륨 수요액을 탄산가스가 더 이상 발생하지 않을 때까지 가하여 중화하고 디클로메탄으로 추출 후 제거한다. 잔사를 실시예 6에서와 같이 재결정하면 백색고체 1.9g(78%)을 얻는다.3.1 g (0.01 mol) of 1-phenyl-6-acetyl-8,8-dimethoxy-3,6-diazaoctan-4-one is added to 10 ml of polyphosphoric acid, and stirred at room temperature for 3 hours, and then diluted with ice water. To the diluent, saturated sodium carbonate demand is added until the carbonic acid gas is no longer generated, neutralized, extracted with dichloromethane and removed. Recrystallization of the residue as in Example 6 yielded 1.9 g (78%) of a white solid.

[실시예 8]Example 8

2-시클로헥산카르보닐-4-옥소-1,2,3,6,7,11b-헥사히드로-4H-피라지노[2,1-a] 이소퀴놀린(I : R1=시클로헥산카르보닐, R2=R3=수소)2-cyclohexanecarbonyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino [2,1-a] isoquinoline (I: R 1 = cyclohexanecarbonyl, R 2 = R 3 = hydrogen)

1-페닐-6-시클로헥산카르보닐-8,8-디메톡시-3,6-디아자옥탄 3.8g(0.01g몰)을 디클로로메탄 10㎖에 용해시키고 포름산 0.5㎖를 가한 후 3시간 환류반응시킨다. 반응액의 용매를 감압하에서 제거하고 잔사에 진한황산 5㎖를 가한 후 상온에서 4시간 교반반응시킨다. 반응물을 얼음물에 가하고 포화탄산나트륨 수용액을 탄산가스가 더 이상 발생하지 않을 때까지 가하여 중화한 후 디클로로메탄으로 추출, 건조한 후 용매를 제거하고 잔사를 에틸아세테이트로 재결정하면 고체 2.6g(82%)을 얻는다.Dissolve 3.8 g (0.01 g mol) of 1-phenyl-6-cyclohexanecarbonyl-8,8-dimethoxy-3,6-diazaoctane in 10 ml of dichloromethane, add 0.5 ml of formic acid, and reflux for 3 hours. Let The solvent in the reaction solution is removed under reduced pressure, 5 ml of concentrated sulfuric acid is added to the residue, and the mixture is stirred at room temperature for 4 hours. The reaction was added to iced water, saturated aqueous sodium carbonate solution was added until neutral carbonic acid was no longer generated, neutralized, extracted with dichloromethane, dried and the solvent was removed. .

Claims (6)

구조식(V) 화합물을 산단독 또는 산과 유기용매 존재하에 고리화하는 구조식(I)의 2-아실-4-옥소-1,3,4,6,7,11b-헥사히드로-4H-피라지노[2,1-a] 이소퀴놀린 유도체의 제조방법2-acyl-4-oxo-1,3,4,6,7,11b-hexahydro-4H-pyrazino of formula (I), wherein the compound of formula (V) is cyclized in the presence of an acid alone or in the presence of an organic solvent. 2,1-a] Method for preparing isoquinoline derivative
Figure kpo00008
Figure kpo00008
구조식(I),(V) 화합물에서 R1은 수소, 탄소수 1-6의 지방족탄화수소이거나, 탄소수 3-7의 시클로알킬기, 또는 벤젠고리에 탄소수 1-6의 지방족알킬기, 할로겐원자가 2-3개까지 치환된 페닐기이다.In the compounds of formulas (I) and (V), R 1 is hydrogen, an aliphatic hydrocarbon having 1-6 carbon atoms, a cycloalkyl group having 3-7 carbon atoms, or an aliphatic alkyl group having 1-6 carbon atoms in the benzene ring, and having 2 to 3 halogen atoms. Is a substituted phenyl group. R2와 R3는 수소, 히드록시기, 또는 탄소수 1-6의 알콕시 또는 탄소수가 1-6의 지방족탄화수소이다. R4는 메틸, 에틸이다.R 2 and R 3 are hydrogen, a hydroxy group, or alkoxy having 1 to 6 carbon atoms or aliphatic hydrocarbon having 1 to 6 carbon atoms. R 4 is methyl, ethyl.
제1항에서, 구조식(V)화합물을 산단독 또는 산과 유기용매 존재하에 고리화하여 구조식(VII)이나 구조식(VIII) 화합물을 제조한 다음 구조식(VII)이나 구조식(VIII) 화합물을 고리화 하는 구조식(I)의 2-아실-4-옥소-1,3,4,6,7,11b-헥사히드로-4H-피라지노[2,1-a] 이소퀴놀린 유도체의 제조방법.The compound of claim 1, wherein the compound of formula (V) is cyclized in the presence of an acid alone or in the presence of an acid and an organic solvent to prepare a compound of formula (VII) or (VIII), and then to a compound of formula (VII) or a formula (VIII). A process for preparing 2-acyl-4-oxo-1,3,4,6,7,11b-hexahydro-4H-pyrazino [2,1-a] isoquinoline derivative of formula (I).
Figure kpo00009
Figure kpo00009
구조식(I)(V)(VII)(VIII)에서 R1,R2,R3,R4는 상기한 바와 같다.R 1 , R 2 , R 3 , R 4 in formula (I) (V) (VII) (VIII) are as described above.
구조식(VI)화합물을 산 단독 또는 산과 유기용매 존재하에 고리화하는 구조식(I)의 2-아실-4-옥소-1,3,4,6,7,11b-헥사히드로-4H-피라지노[2,1-a] 이소퀴놀린 유도체의 제조방법2-acyl-4-oxo-1,3,4,6,7,11b-hexahydro-4H-pyrazino [1] of formula (I), wherein the compound of formula (VI) is cyclized in the presence of an acid alone or in the presence of an organic solvent. 2,1-a] Method for preparing isoquinoline derivative
Figure kpo00010
Figure kpo00010
구조식(I)(VI)에서 R1,R2,R3,R4는 상기한 바와 같다.R 1 , R 2 , R 3 , R 4 in formula (I) (VI) are as described above.
제3항에서, 구조식(VI)화합물을 산 단독 또는 유기용매 존재하에 고리화하여 구조식(VIII)화합물을 제조한 다음 구조식(VIII) 화합물을 고리화하는 구조식(I)의 2-아실-4-옥소-1,3,4,6,7,11b-헥사히드로-4H-피라지노 [2,1-a]이소퀴놀린 유도체의 제조방법.The compound of claim 3, wherein the compound of formula (VI) is cyclized in the presence of an acid alone or in an organic solvent to prepare a compound of formula (VIII), and then 2-acyl-4- of formula (I) to cyclize the compound of formula (VIII). Method for preparing oxo-1,3,4,6,7,11b-hexahydro-4H-pyrazino [2,1-a] isoquinoline derivative.
Figure kpo00011
Figure kpo00011
구조식(I)(VI)(VII)에서 R1,R2,R3,R4는 상기한 바와 같다.R 1 , R 2 , R 3 , R 4 in formula (I) (VI) (VII) are as described above.
특허 청구의 범위 제1 또는 제3항에서 사용하는 산을 황산, 염산, 인산, 폴리인산, 메탄설포산, 포름산, 아세트산, 트리클로로아세트산, 트리플루오로아세트산, 보론트리플루오로에테르, 부가물, p-톨루엔 설폰산 중에서 선택하는 방법.The acid used in claim 1 or 3 may be sulfuric acid, hydrochloric acid, phosphoric acid, polyphosphoric acid, methanesulfonic acid, formic acid, acetic acid, trichloroacetic acid, trifluoroacetic acid, borontrifluoroether, adduct, p-toluene sulfonic acid. 특허청구의 범위 제1 또는 제3항에서 사용하는 유기용매를 디클로로메탄, 클로로포름, 사염화탄소, 디클로로에탄, 아세토니트릴, 디에틸에테르, 디옥산, 테트라하이드로푸란중에서 선택하는 방법.Claims The method of selecting the organic solvent used in Claim 1 or 3 from dichloromethane, chloroform, carbon tetrachloride, dichloroethane, acetonitrile, diethyl ether, dioxane, tetrahydrofuran.
KR1019830002418A 1982-07-08 1983-05-31 Process for preparing 2-acyl-4-oxo-1,3,4,6,7,11b-hexahydro-4h-pyrazino(2,1-a)isoquinoline derivatives KR850001227B1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
KR1019830002418A KR850001227B1 (en) 1983-05-31 1983-05-31 Process for preparing 2-acyl-4-oxo-1,3,4,6,7,11b-hexahydro-4h-pyrazino(2,1-a)isoquinoline derivatives
IN823/CAL/83A IN157936B (en) 1982-07-08 1983-07-02
GB08318371A GB2126212B (en) 1982-07-08 1983-07-07 Process for the production of (+)-4-oxo-1 2 3 6 7 11b-hexahydro-4h-pyrazino(2 1-a)isoquinoline derivatives
IT67737/83A IT1193429B (en) 1982-07-08 1983-07-07 PROCEDURE FOR THE PRODUCTION OF DERIVATIVES OF 4 OXO 1 2 3 6 7 11B HEXAIDRO 4H PIRAZINO 2 1 A ISOCHINO LINA
DE3324532A DE3324532C2 (en) 1982-07-08 1983-07-07 Process for the preparation of (±) -4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino [2,1-a] isoquinoline derivatives
US06/511,999 US4497952A (en) 1982-07-08 1983-07-08 Process for the production of (±)-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinoline derivatives
KR1019850003493A KR850001474B1 (en) 1983-05-31 1985-05-22 Process for the preparation of 1-phenyl-3(2,2-dialkoxy)ethyl-3,6-diazaheptane-4,7-dione derivation
KR1019850003492A KR850001473B1 (en) 1983-05-31 1985-05-22 Process for the preparation of 1-phenyl-8,8-dialkoxy-3,6-diazooctane-4-one derivation
IN438/CAL/85A IN159586B (en) 1982-07-08 1985-06-11

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019830002418A KR850001227B1 (en) 1983-05-31 1983-05-31 Process for preparing 2-acyl-4-oxo-1,3,4,6,7,11b-hexahydro-4h-pyrazino(2,1-a)isoquinoline derivatives

Related Child Applications (2)

Application Number Title Priority Date Filing Date
KR1019850003493A Division KR850001474B1 (en) 1983-05-31 1985-05-22 Process for the preparation of 1-phenyl-3(2,2-dialkoxy)ethyl-3,6-diazaheptane-4,7-dione derivation
KR1019850003492A Division KR850001473B1 (en) 1983-05-31 1985-05-22 Process for the preparation of 1-phenyl-8,8-dialkoxy-3,6-diazooctane-4-one derivation

Publications (2)

Publication Number Publication Date
KR840009309A KR840009309A (en) 1984-12-26
KR850001227B1 true KR850001227B1 (en) 1985-08-23

Family

ID=19229069

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1019830002418A KR850001227B1 (en) 1982-07-08 1983-05-31 Process for preparing 2-acyl-4-oxo-1,3,4,6,7,11b-hexahydro-4h-pyrazino(2,1-a)isoquinoline derivatives
KR1019850003493A KR850001474B1 (en) 1983-05-31 1985-05-22 Process for the preparation of 1-phenyl-3(2,2-dialkoxy)ethyl-3,6-diazaheptane-4,7-dione derivation
KR1019850003492A KR850001473B1 (en) 1983-05-31 1985-05-22 Process for the preparation of 1-phenyl-8,8-dialkoxy-3,6-diazooctane-4-one derivation

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1019850003493A KR850001474B1 (en) 1983-05-31 1985-05-22 Process for the preparation of 1-phenyl-3(2,2-dialkoxy)ethyl-3,6-diazaheptane-4,7-dione derivation
KR1019850003492A KR850001473B1 (en) 1983-05-31 1985-05-22 Process for the preparation of 1-phenyl-8,8-dialkoxy-3,6-diazooctane-4-one derivation

Country Status (1)

Country Link
KR (3) KR850001227B1 (en)

Also Published As

Publication number Publication date
KR850001474B1 (en) 1985-10-10
KR850001473B1 (en) 1985-10-10
KR840009309A (en) 1984-12-26

Similar Documents

Publication Publication Date Title
KR100352212B1 (en) Method for preparing 4a, 5,9,10,11,12-hexahydro-6H-benzofuro [3a, 3,2-ef] [2] benzazin derivative
IE60272B1 (en) "Process for the preparation of herbicidal 2-(4,4-disubtituted 5-oxo-2-imidazolin-2-yl) benzoic, nicotinic and quinoline-3-carboxylic acids, esters and salts"
JP2002511440A (en) Oxidation method using TEMPO
GB2126212A (en) Process for the production of (+/-)-4-oxo-1,2,3,6,7,11b-hexahydro- 4H-pyrazino(2,1-a]isoquinoline derivatives
KR850001227B1 (en) Process for preparing 2-acyl-4-oxo-1,3,4,6,7,11b-hexahydro-4h-pyrazino(2,1-a)isoquinoline derivatives
SE441448B (en) SET TO MAKE HEXAHYDRO-GAMMA CARBOL COMPOUNDS
US5849945A (en) Aminotetralone derivatives and preparation process thereof
US3922285A (en) Process for the methylenation of catechols
US3726924A (en) Method for the preparation of tris (dimethylamino) methane
IE920495A1 (en) New phenylethanolamino- and phenylethanolaminomethyltetralines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
HUT68198A (en) Process for producing hydroxyalkane carboxylic acid amides
KR20010005943A (en) Process for preparing 0-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides
JPH0231075B2 (en)
SU566521A3 (en) Method of obtaining lactams
US4963684A (en) Process for preparing cotarnine
US5430176A (en) Intermediate used for the preparation of deferoxamine
US3758546A (en) Methoxy amine derivatives and process for preparing them
HU181503B (en) Process for producing 3,3-ethylenedioxy-4,5-seco-19-nor-androst-9-ene-5,17-dione
HUT70557A (en) N,n'-disubstituted amine derivative, pharmaceutical compositions containing them and process for producing the compounds and the compositions
US3978126A (en) N-hydroxy-amidine compounds
IE41499B1 (en) Process for preparing 6-chloro-2-chloromethyl-4-phenylquinazoline-3-oxide and intermediates therefor
HU223138B1 (en) Novel process for producing alkyl-4,6,7,8,9,9a-hexahydro-2h,3h-pyrido[1,2-a]pyrazin-1-on-7-carboxylate esters
KR840000250B1 (en) Process for preparing 4-oxo-1,3,4,6,7,11b-hexahydro-4h-pyrazino (2,1-a) isoquinolin derivatives
WO2002102803A1 (en) Total synthesis of galanthamine, analogues and derivatives thereof
JP3496979B2 (en) Process for producing substituted indole-3-acetic acid compound and substituted benzofuranyl-3-acetic acid compound

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19970619

Year of fee payment: 13

LAPS Lapse due to unpaid annual fee